Actelion SWOT Analysis, Competitors, Segmentation, Target Market, Positioning & USP

Published by MBA Skool Team, Last Updated: April 12, 2020

SWOT analysis of Actelion analyses the brand/company with its strengths, weaknesses, opportunities & threats. In Actelion SWOT Analysis, the strengths and weaknesses are the internal factors whereas opportunities and threats are the external factors.

SWOT Analysis is a proven management framework which enables a brand like Actelion to benchmark its business & performance as compared to the competitors and industry. As of 2020, Actelion is one of the leading brands in the pharma and healthcare sector.

The table below lists the SWOT (Strengths, Weaknesses, Opportunities, Threats), top Actelion competitors and includes Actelion target market, segmentation, positioning & Unique Selling Proposition (USP).

Actelion SWOT Analysis, Competitors, Segmentation, Target Market, Positioning, USP & Brand Analysis Table
Actelion Brand Analysis
Parent Company

Actelion

Category

Pharmaceutical

Sector

Pharma and Healthcare

Tagline/ Slogan

Together we innovate

USP

Actelion operates in niche segment of orphan diseases

Actelion STP
Actelion Segmentation

Orphan diseases such as digital ulcers, gaucher’s disease

Actelion Target Market

Healthcare professionals operating in these areas

Actelion Positioning

Actelion is company which blends biotechnological innovation with pharmaceutical discipline

Actelion SWOT Analysis
Actelion Strengths

Below are the Strengths in the SWOT Analysis of Actelion:

1. Actelion operates in niche segment of orphan diseases which have less competition

2. Strong presence in over 60 plus markets

3. Key drugs in the late stages of development in pipeline

4. Longer patent life of key drugs

5. Over 2500+ well trained employees

Actelion Weaknesses

Here are the weaknesses in the Actelion SWOT Analysis:

1. Limited presence in emerging markets

2. They have only four blockbuster drugs

Actelion Opportunities

Following are the Opportunities in Actelion SWOT Analysis:

1. Diversify portfolio in specialty diseases

2. Contract manufacturing of G.P diseases

3. Market introduction of Cadazolid

Actelion Threats

The threats in the SWOT Analysis of Actelion are as mentioned:

1. Increasing pressure to reduce prices in Europe

2. Growing number of generic drugs

3. Global economic slowdown

Actelion Competition
Competitors

Below are the top 4 Actelion competitors:

1. Abbott laboratories
2. Amicus therapeutics Inc

3. Aradigm corporation

4. AstraZeneca


This article has been researched & authored by the Content & Research Team. It has been reviewed & published by the MBA Skool Team. The content on MBA Skool has been created for educational & academic purpose only.

Similar analysis has also been done for the competitors of the company belonging to the same category, sector or industry. Browse marketing analysis of more brands and companies similar to Actelion. The BrandGuide section covers SWOT Analysis, Competitors, Segmentation, Target Market, Positioning & USP of more than 2800 brands from over 20 industry sectors.

Search & Explore : BrandGuide


The brand names and other brand information used in the BrandGuide section are properties of their respective companies. The companies are not associated with MBA Skool in any way.
Edit the Brand or Add a New One : Contribute to BrandGuide
Share this Page on:
Facebook ShareTweetShare on Linkedin